RT-01
/ Bengbu Medical College
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 29, 2022
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=7 | Recruiting | Sponsor: First Affiliated Hospital Bengbu Medical College | Not yet recruiting ➔ Recruiting | Initiation date: Jun 2022 ➔ Feb 2022
Enrollment open • Oncolytic virus • Trial initiation date • Oncology • Solid Tumor
May 24, 2022
Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma
(clinicaltrials.gov)
- P1 | N=6 | Not yet recruiting | Sponsor: First Affiliated Hospital Bengbu Medical College
New P1 trial • Oncolytic virus • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma
1 to 2
Of
2
Go to page
1